Biography
Dr. Haita Makanji joined Magellan Rx Management in 2014. She is the vice president of clinical strategy and innovation within specialty in which she assumes several roles and responsibilities, including development and management of specialty clinical programs and interfacing with payers and pharmaceutical companies to bring industry-leading solutions that curb rising specialty spend. She is responsible for design, implementation, and operations of specialty clinical programs that improve the quality of care for patients with high-cost disease states across several lines of business including employer groups and Medicaid plans. She oversees the Comprehensive Oncology Management Program which encompasses innovative utilization management strategies with complex case management. Additionally, Dr. Makanji leads a team of pharmacists, including board-certified oncology pharmacists who are tasked to support payers and assist with comprehensive medical and pharmacy data analyses, prior authorization and medical policy design, and organizing unique key opinion leader thought leadership panels.

Clinical Dx Showcase:
Magellan Rx Management
Magellan Rx Management, a division of Magellan Health, Inc., is shaping the future of pharmacy. As a next-generation pharmacy organization, we deliver meaningful solutions to the people we serve. As pioneers in specialty drug management, industry leaders in Medicaid pharmacy programs and disruptors in pharmacy benefit management, we partner with our customers and members to deliver a best-in-class healthcare experience.

Collaborative Precision Medicine Platform Accelerates Biomarker Adoption
The lag in biomarker adoption is preventing patients from accessing life-extending precision therapies and trials. Learn about the only collaborative, decision-support platform that aligns oncologists, labs and payers, streamlines ordering and ensures the right biomarkers are tested every time.